logo image

Filter by:

FDA Grants Accelerated Approval For Alzheimer’s ...
Gordon Woo
Gordon Woo January 17, 2023

Launched in 2009, the rationale for the RMS® Longevity Risk Model was to bring state-of-the-art developments in the science of aging to the…

New Milestone on The Path To A Universal Flu Vac...
Gordon Woo
Gordon Woo December 02, 2022

The West African Ebola crisis which peaked in 2014 was a near-miss pandemic. Given the slowness of international financial assistance with…

Looking at Long COVID
Gordon Woo
Gordon Woo July 19, 2022

A sizeable proportion of people who recover from COVID-19 may then go on to experience some lingering symptoms. The most common of these are…

Learning From the 2022 Monkeypox Outbreak
Gordon Woo
Gordon Woo June 07, 2022

Every unusual hazardous event offers lessons for enhancing risk assessment.  Monkeypox has been on the RMS® infectious disease threat horizon…

Make Sense of Mortality Risk With RMS LifeRisks
Ashley Campbell
Ashley Campbell December 13, 2021

Understanding and projecting future mortality requires consideration of the widest set of relevant risk drivers, or a view of risk could be…

Launch of New Vaccine Initiative to Dramatically...
Gordon Woo
Gordon Woo April 14, 2021

On March 10, 2021, in Oslo, Norway, the Coalition for Epidemic Preparedness Innovations (CEPI) – a global partnership between public, private…

CTA

Subscribe to Our Newsletter

close button
Overlay Image
Video Title

Thank You

You’ll be contacted by an Moody's RMS specialist shortly.